de Northern Trust Corcept Therapeutics CORT Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 65.5 M | Comprar |
753,796
+110,638
| +17% | +USD 6.68 M | 0.01% | 1031 |
|
|
2026
Q1 | USD 25.9 M | Comprar |
643,158
+14,083
| +2% | +USD 527 k | ﹤0.01% | 1508 |
|
|
2025
Q4 | USD 21.9 M | Vender |
629,075
-13,251
| -2% | -USD 1.04 M | ﹤0.01% | 1596 |
|
|
2025
Q3 | USD 53.4 M | Vender |
642,326
-9,977
| -2% | -USD 722 k | 0.01% | 1091 |
|
|
2025
Q2 | USD 47.9 M | Vender |
652,303
-369,698
| -36% | -USD 26.8 M | 0.01% | 1131 |
|
|
2025
Q1 | USD 117 M | Comprar |
1,022,001
+6,486
| +0.6% | +USD 395 k | 0.02% | 650 |
|
|
2024
Q4 | USD 51.2 M | Comprar |
1,015,515
+94,128
| +10% | +USD 4.93 M | 0.01% | 1113 |
|
|
2024
Q3 | USD 42.6 M | Vender |
921,387
-10,821
| -1% | -USD 385 k | 0.01% | 1130 |
|
|
2024
Q2 | USD 30.3 M | Vender |
932,208
-31,235
| -3% | -USD 856 k | 0.01% | 1293 |
|
|
2024
Q1 | USD 24.3 M | Vender |
963,443
-128,055
| -12% | -USD 3.03 M | ﹤0.01% | 1461 |
|
|
2023
Q4 | USD 35.5 M | Vender |
1,091,498
-191,805
| -15% | -USD 5.27 M | 0.01% | 1255 |
|
|
2023
Q3 | USD 35 M | Vender |
1,283,303
-2,318
| -0.2% | -USD 67.1 k | 0.01% | 1170 |
|
|
2023
Q2 | USD 28.6 M | Vender |
1,285,621
-65,973
| -5% | -USD 1.52 M | 0.01% | 1346 |
|
|
2023
Q1 | USD 29.3 M | Comprar |
1,351,594
+327,128
| +32% | +USD 7.17 M | 0.01% | 1302 |
|
|
2022
Q4 | USD 20.8 M | Comprar |
1,024,466
+27,149
| +3% | +USD 681 k | ﹤0.01% | 1491 |
|
|
2022
Q3 | USD 25.6 M | Vender |
997,317
-176
| -0% | -USD 4.71 k | 0.01% | 1303 |
|
|
2022
Q2 | USD 23.7 M | Vender |
997,493
-40,470
| -4% | -USD 882 k | 0.01% | 1405 |
|
|
2022
Q1 | USD 23.4 M | Vender |
1,037,963
-94,499
| -8% | -USD 2.01 M | ﹤0.01% | 1559 |
|
|
2021
Q4 | USD 22.4 M | Vender |
1,132,462
-51,795
| -4% | -USD 1.05 M | ﹤0.01% | 1678 |
|
|
2021
Q3 | USD 23.3 M | Vender |
1,184,257
-25,576
| -2% | -USD 535 k | ﹤0.01% | 1685 |
|
|
2021
Q2 | USD 26.6 M | Vender |
1,209,833
-34,919
| -3% | -USD 777 k | ﹤0.01% | 1687 |
|
|
2021
Q1 | USD 29.6 M | Vender |
1,244,752
-61,309
| -5% | -USD 1.64 M | 0.01% | 1541 |
|
|
2020
Q4 | USD 34.2 M | Vender |
1,306,061
-27,683
| -2% | -USD 583 k | 0.01% | 1385 |
|
|
2020
Q3 | USD 23.2 M | Vender |
1,333,744
-70,843
| -5% | -USD 1.13 M | 0.01% | 1512 |
|
|
2020
Q2 | USD 23.6 M | Comprar |
1,404,587
+93,569
| +7% | +USD 1.31 M | 0.01% | 1476 |
|
|
2020
Q1 | USD 15.6 M | Comprar |
1,311,018
+19,718
| +2% | +USD 244 k | ﹤0.01% | 1575 |
|
|
2019
Q4 | USD 15.6 M | Vender |
1,291,300
-7,116
| -0.5% | -USD 99.1 k | ﹤0.01% | 1902 |
|
|
2019
Q3 | USD 18.4 M | Comprar |
1,298,416
+6,423
| +0.5% | +USD 78.9 k | ﹤0.01% | 1744 |
|
|
2019
Q2 | USD 14.4 M | Comprar |
1,291,993
+10,825
| +0.8% | +USD 121 k | ﹤0.01% | 1909 |
|
|
2019
Q1 | USD 15 M | Vender |
1,281,168
-21,312
| -2% | -USD 265 k | ﹤0.01% | 1885 |
|
|
2018
Q4 | USD 17.4 M | Vender |
1,302,480
-8,956
| -0.7% | -USD 118 k | ﹤0.01% | 1690 |
|
|
2018
Q3 | USD 18.4 M | Comprar |
1,311,436
+63,994
| +5% | +USD 894 k | ﹤0.01% | 1848 |
|
|
2018
Q2 | USD 19.6 M | Comprar |
1,247,442
+130,839
| +12% | +USD 2.28 M | 0.01% | 1795 |
|
|
2018
Q1 | USD 18.4 M | Comprar |
1,116,603
+5,342
| +0.5% | +USD 99 k | ﹤0.01% | 1747 |
|
|
2017
Q4 | USD 20.1 M | Comprar |
1,111,261
+3,039
| +0.3% | +USD 55 k | 0.01% | 1699 |
|
|
2017
Q3 | USD 21.4 M | Comprar |
1,108,222
+20,295
| +2% | +USD 303 k | 0.01% | 1664 |
|
|
2017
Q2 | USD 12.8 M | Comprar |
1,087,927
+164,732
| +18% | +USD 1.79 M | ﹤0.01% | 2002 |
|
|
2017
Q1 | USD 10.1 M | Comprar |
923,195
+52,274
| +6% | +USD 459 k | ﹤0.01% | 2114 |
|
|
2016
Q4 | USD 6.32 M | Comprar |
870,921
+14,623
| +2% | +USD 115 k | ﹤0.01% | 2390 |
|
|
2016
Q3 | USD 5.57 M | Comprar |
856,298
+19,929
| +2% | +USD 116 k | ﹤0.01% | 2454 |
|
|
2016
Q2 | USD 4.57 M | Comprar |
836,369
+121,955
| +17% | +USD 634 k | ﹤0.01% | 2531 |
|
|
2016
Q1 | USD 3.34 M | Comprar |
714,414
+20,194
| +3% | +USD 78.7 k | ﹤0.01% | 2670 |
|
|
2015
Q4 | USD 3.46 M | Comprar |
694,220
+17,690
| +3% | +USD 79.8 k | ﹤0.01% | 2703 |
|
|
2015
Q3 | USD 2.54 M | Comprar |
676,530
+75,869
| +13% | +USD 385 k | ﹤0.01% | 2895 |
|
|
2015
Q2 | USD 3.61 M | Comprar |
600,661
+15,478
| +3% | +USD 94.9 k | ﹤0.01% | 2724 |
|
|
2015
Q1 | USD 3.28 M | Comprar |
585,183
+11,482
| +2% | +USD 41.6 k | ﹤0.01% | 2790 |
|
|
2014
Q4 | USD 1.72 M | Vender |
573,701
-26,875
| -4% | -USD 81.9 k | ﹤0.01% | 3190 |
|
|
2014
Q3 | USD 1.61 M | Vender |
600,576
-5,296
| -0.9% | -USD 14 k | ﹤0.01% | 3233 |
|
|
2014
Q2 | USD 1.7 M | Vender |
605,872
-50,254
| -8% | -USD 148 k | ﹤0.01% | 3170 |
|
|
2014
Q1 | USD 2.86 M | Vender |
656,126
-56,498
| -8% | -USD 197 k | ﹤0.01% | 2925 |
|
|
2013
Q4 | USD 2.29 M | Comprar |
712,624
+13,597
| +2% | +USD 27.5 k | ﹤0.01% | 3070 |
|
|
2013
Q3 | USD 1.11 M | Comprar |
699,027
+44,156
| +7% | +USD 77.9 k | ﹤0.01% | 3305 |
|
|
2013
Q2 | USD 1.13 M | Comprar |
+654,871
| Nuevas | +USD 1.18 M | ﹤0.01% | 3232 |
|
Otros fondos que tienen CORT en su cartera
Posición de Northern Trust en CORT: resumen de T2 2026
Northern Trust aumentó su participación en Corcept Therapeutics (CORT) en 17% durante T2 2026, al comprar aproximadamente USD 6.68 M y elevar la posición a 753,796 acciones con un valor de USD 65.5 M. La posición representa 0.01% de la cartera y ocupa el puesto #1031.
Northern Trust reportó por primera vez una posición en CORT en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 117 M en T1 2025. Al cierre de T2 2026, 423 fondos que sigue Wall St. Rank mantienen una posición en CORT.
- Al cierre de T2 2026, Northern Trust tenía 753,796 acciones de Corcept Therapeutics con un valor de USD 65.5 M.
- Northern Trust compró 110,638 acciones de Corcept Therapeutics en T2 2026, por un monto estimado de USD 6.68 M.
- Corcept Therapeutics representó 0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 1031.
- Northern Trust reportó por primera vez una posición en Corcept Therapeutics en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en Corcept Therapeutics alcanzó su máximo de USD 117 M en T1 2025.
- Al cierre de T2 2026, 423 fondos que sigue Wall St. Rank tenían Corcept Therapeutics en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.